Verdaguer, Ignasi Bofill; Alba, Camila Andrea Zafra 
; Sussmann, R. A. C.; Zuluaga, Norma Lucía Buriticá ; Melo, H. R.; Azevedo, M. F.; Almeida, F. G.; Kimura, Emilia Akemi Shiraishi; Katzin, Alejandro Miguel
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, OXIGÊNIO, ANIMAIS PARASITOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERDAGUER, Ignasi Bofill et al. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria. Antimicrobial Agents and Chemotherapy, v. 65, n. 4, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.1128/AAC.01516-20. Acesso em: 27 nov. 2025.APA
Verdaguer, I. B., Alba, C. A. Z., Sussmann, R. A. C., Zuluaga, N. L. B., Melo, H. R., Azevedo, M. F., et al. (2021). Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria. Antimicrobial Agents and Chemotherapy, 65( 4), 1-19. doi:10.1128/AAC.01516-20NLM
Verdaguer IB, Alba CAZ, Sussmann RAC, Zuluaga NLB, Melo HR, Azevedo MF, Almeida FG, Kimura EAS, Katzin AM. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 4): 1-19.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.01516-20Vancouver
Verdaguer IB, Alba CAZ, Sussmann RAC, Zuluaga NLB, Melo HR, Azevedo MF, Almeida FG, Kimura EAS, Katzin AM. Exploring ubiquinone biosynthesis inhibition as a strategy for improving atovaquone efficacy in Malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 4): 1-19.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.01516-20
